← SynDRA
CAPIVASERTIB
SynDRA canonical compound SYN0036679 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | AKT1 | AKT2 | AKT3 |
| Mechanism of action | AKT inhibitor |
All known targets
Mechanisms of action (all sources)
- AKT2 INHIBITOR
- Serine/threonine-protein kinase AKT inhibitor
- AKT3 INHIBITOR
- AKT1 INHIBITOR
- AKT3 MODULATOR
Drug classes
- Antineoplastic Agents
- Protein Kinase Inhibitors
ATC classes
- L01E · PROTEIN KINASE INHIBITORS
Cross-references
Synonyms
- AZD-5363
- AZC5363
- AZD5363
- CAPIVASERTIB (AZD5363)
- Truqap
- AZD 5363
- UNII-WFR23M21IE
- WFR23M21IE
- cc-638
- 4-Amino-N-[(1s)-1-(4-Chlorophenyl)-3-Hydroxypropyl]-1-(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)piperidine-4-Carboxamide
- C21H25ClN6O2
- (S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE
- 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide
- 4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1
- 4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-
- CHEMBL2325741
- Capivasertib?
- 4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide
- 4-PIPERIDINECARBOXAMIDE, 4-AMINO-N-((1S)-1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-
- Capivasertib (JAN/USAN)
- CAPIVASERTIB [INN]
- CAPIVASERTIB [JAN]
- CAPIVASERTIB [USAN]
- Capivasertib (AZD5363)
- MLS006011179
- CAPIVASERTIB [WHO-DD]
- SCHEMBL390243
- GTPL7709
- DTXSID40150710
- EX-A285
- US10654855, Example 9
- BDBM443385
- MFCD22628785
- NSC764039
- NSC782347
- NSC799347
- s8019
- ZINC43204023
Look up CAPIVASERTIB in the interactive SynDRA portal →